Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A1 | P30531 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 7/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 7/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 7/20 | 0.48 |
| ▸ | DRD2 | P14416 | 7/20 | 0.48 |
| ▸ | DRD4 | P21917 | 7/20 | 0.48 |
| ▸ | DRD3 | P35462 | 7/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6964631 | 0.90 | SLC6A1 (0.53) | SLC6A1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL8172344 | 0.88 | CHRM1 (0.62) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL7608441 | 0.86 | SLC6A1 (0.57) | SLC6A1CHRM2CHRM4CHRM5CHRM1 | |
| Hydrochloric Acid SCHEMBL8180665 | 0.85 | SLC6A1 (0.56) | SLC6A1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL8196471 | 0.84 | SLC6A1 (0.63) | SLC6A1DRD2 | |
| SCHEMBL8196728 | 0.84 | SLC6A1 (0.63) | SLC6A1DRD2 | |
| SCHEMBL8199176 | 0.82 | SLC6A1 (0.63) | SLC6A1DRD2 | |
| SCHEMBL8187340 | 0.81 | SLC6A1 (0.59) | SLC6A1DRD2 | |
| SCHEMBL6968776 | 0.80 | CHRM1 (0.59) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL5495902 | 0.79 | SLC6A1 (0.59) | SLC6A1CHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6114354-A | N-substituted azaheterocyclic compounds | NOVO NORDISK A/S (DK) | 2000-09-05 | — | — | US | disclosed |
| US-6100253-A | 3-(1-(3-(XANTHEN-9-YLIDENE)-1-PROPYL)PIPERIDIN-4-YL)PROPIONIC ACID, FOR EXAMPLE; TREATING NON-INSULIN DEPENDENT DIABETES, NEUROGENIC INFLAMMATION AND OBESITY; INTERFERE WITH C-FIBERS TO INHIBIT SECRETION OF INSULIN ANTAGONISING PEPTIDES | NOVO NORDISK A/S (DK) | 2000-08-08 | — | — | US | disclosed |
| US-6066632-A | ANALGESICS; ANTIINFLAMMATORY AGENTS | NOVO NORDISK A/S (DK) | 2000-05-23 | — | — | US | disclosed |
| EP-0991621-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 2000-04-12 | — | — | EP | disclosed |
| US-6040318-A | TREATING INSULIN RESISTANT NON-INSULIN-DEPENDENT DIABETES MELLITUS AND AGEING-ASSOCIATED OBESITY, NEUROGENIC INFLAMMATION ASSOCIATED WITH NEUROPATHY OR RHEUMATOID ARTHRITIS | NOVO NORDISK A/S (DK) | 2000-03-21 | — | — | US | disclosed |
| WO-1999000367-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1999-01-07 | — | — | WO | disclosed |